financetom
Business
financetom
/
Business
/
Hca Healthcare Insider Sold Shares Worth $494,400, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hca Healthcare Insider Sold Shares Worth $494,400, According to a Recent SEC Filing
May 8, 2024 3:24 PM

05:48 PM EDT, 05/08/2024 (MT Newswires) -- Michael S. Cuffe, Executive Vice President and Chief Clinical Officer, on May 06, 2024, sold 1,600 shares in Hca Healthcare ( HCA ) for $494,400. Following the Form 4 filing with the SEC, Cuffe has control over a total of 34,124 shares of the company, with 34,124 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/860730/000120919124005570/xslF345X03/doc4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: Chinese Tech Giants Turn to Local AI Chips Instead of Nvidia Due to US Restrictions
Update: Market Chatter: Chinese Tech Giants Turn to Local AI Chips Instead of Nvidia Due to US Restrictions
May 30, 2025
09:15 AM EDT, 05/30/2025 (MT Newswires) -- (Updates with Nvidia's ( NVDA ) declining to comment in fifth paragraph.) Alibaba ( BABA ) , Baidu ( BIDU ) , and other Chinese tech giants are aiming to shift toward domestic AI chips instead of Nvidia ( NVDA ) due to tightened US export controls, the Financial Times reported Thursday, citing...
Zscaler Had 'Breakout' Third Quarter Amid Strong Demand for AI Security Solutions, Wedbush Says
Zscaler Had 'Breakout' Third Quarter Amid Strong Demand for AI Security Solutions, Wedbush Says
May 30, 2025
09:19 AM EDT, 05/30/2025 (MT Newswires) -- Zscaler's ( ZS ) fiscal third-quarter results marked another breakout moment for the company as it continues to see strong demand for its artificial intelligence security offerings and zero trust platform, Wedbush Securities said in a Friday note. The cloud security company said late Thursday that it now expects calculated billings to be...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Summit Says Ivonescimab Significantly Improves Progression-Free Survival; Overall Survival Trend Not Statistically Significant -- Shares Drop
Summit Says Ivonescimab Significantly Improves Progression-Free Survival; Overall Survival Trend Not Statistically Significant -- Shares Drop
May 30, 2025
09:20 AM EDT, 05/30/2025 (MT Newswires) -- Summit Therapeutics ( SMMT ) said Friday that its late-stage study of ivonescimab plus chemotherapy met the progression-free survival primary endpoint in patients with EGFR-mutated non-small cell lung cancer. The treatment reduced the risk of disease progression or death by 48% compared to chemotherapy alone, with consistent results seen across Asian and non-Asian...
Copyright 2023-2026 - www.financetom.com All Rights Reserved